Terminated PHASE2 INTERVENTIONAL 1-arm NCT00919984

Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer

Phase II Clinical Trial of Intravenous Paclitaxel and Carboplatin Plus Intraperitoneal Paclitaxel as an Adjuvant Chemotherapy in Patients With Optimally Debulked Advanced Epithelial Ovarian Carcinoma

Sponsor: Korea Cancer Center Hospital

Conditions Ovarian Neoplasms

Interventions IP chemotherapy

Updated 6 times since 2017 Last updated: May 7, 2014 Started: May 31, 2007 Primary completion: Oct 31, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This study stopped due to slow accrual.

Other terminated trials from Korea Cancer Center Hospital

More terminations from Korea Cancer Center Hospital

Other Ovarian Neoplasms trials with similar outcome

Browse all Ovarian Neoplasms trials

A PHASE2 clinical study on Ovarian Neoplasms, this trial is terminated or withdrawn. The trial is conducted by Korea Cancer Center Hospital and has accumulated 6 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Korea Cancer Center Hospital

Data source: Korea Cancer Center Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea